期刊文献+

免疫印迹法检测老年2型糖尿病患者血清胰岛自身抗体的临床价值 被引量:1

Determination of islet autoantibodies in elderly diabetic patients by immunoblotting test
下载PDF
导出
摘要 目的评价免疫印迹法检测老年2型糖尿病患者胰岛自身抗体(IAA)的临床价值。方法采用免疫印迹(IB)法和酶联免疫吸附(ELISA)法分别检测350例老年2型糖尿病患者和120例健康对照组血清谷氨酸脱羧酶抗体(GADA)、胰岛细胞抗体(ICA)和IAA,比较不同方法检测胰岛相关抗体的阳性率。结果在老年2型糖尿病患者中,IB法检测GADA阳性患者为56例,ELISA法检测阳性患者为38例,IB法检测的阳性率要明显高于ELISA法,而2种方法检测ICA、IAA的阳性率比较无明显差异。2种方法检测病程≥5年患者GADA、ICA的阳性率均低于病程<5年患者,但IB法检测GADA的阳性率要高于ELISA法。结论IB法在检测老年2型糖尿病患者IAA尤其是GADA的敏感性要优于ELISA法。 ObjectiveTo estimate the value of immunoblotting test in detecting islet autoantibodies (IAA) of elderly diabetic patients.MethodsThree hundred and fifty elderly diabetic patients and one hundred and twenty healthy people were measured for autoantibodies:glutamic acid decarboxylase antibody(GADA),islet cell antibody (ICA)and IAA with immunoblotting test and ELISA respectively.ResultsThe positive rate of GADA with immunoblotting test was higher than that with ELISA in elderly diabetic patients whereas there were no significant differences in the positive rates of ICA and IAA between two methods. The positive rates of GADA and ICA in patients with a course more than five years were lower than patients with a course less than five years with two methods. The positive rate of GADA with immunoblotting test was higher than that with ELISA in patients with a course more than five years.ConclusionsThe sensibility of immunoblotting test was better than ELISA in detecting IAA in elderly diabetic patients, especially for GADA.
出处 《实用老年医学》 CAS 2010年第2期156-158,共3页 Practical Geriatrics
关键词 免疫印迹法 2型糖尿病 胰岛自身抗体 immunoblotting test type 2 diabetes mellitus islet autoantibodies
  • 相关文献

参考文献10

二级参考文献48

  • 1周智广,李霞.成人隐匿性自身免疫糖尿病研究的新进展[J].中国医学科学院学报,2003,25(5):630-634. 被引量:13
  • 2杨琳,周智广,黄干,颜湘,欧阳玲莉,伍汉文.LADA患者胰岛β细胞功能的前瞻性研究[J].中华内分泌代谢杂志,2003,19(4):263-266. 被引量:30
  • 3潘孝仁,杨文英,肖建中,陈仕明.成人晚发自身免疫性糖尿病的特点及诊断要点探讨[J].中华内科杂志,1997,36(3):159-164. 被引量:67
  • 4[1]Paul Z, Merrill R,Robert T,et al. Crucial points at diagnosis-type 2diabetes or slow type 1 diabetes. Diabetes Caree, 1999,22(Suppl 2) :B59
  • 5[2]Riley MD,McCarty DJ, Couper DJ, et al. The 1984 Tasmanian insulin trented diabetes mellitus prevalence cohort: an 8.5 year mortality follow-up investigatin. Diabetes Res Clin Pract, 1995,29(1):27
  • 6[3]Tuomi T, Groop LC,Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes, 1993,42(3) :358
  • 7[1]Bingley PJ, Bonifacio E, Mueller PW. Diabetes antibody standardization program: first assay proficiency evaluation. Daibetes 2003;52:1128- 1136.
  • 8[2]Krischer JP, Cuthbertson DD, Yu L, et al. Screening strategies for the indentificstion of multiple antibody - positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab 2003;88:103-108.
  • 9[3]Hamalainen AM, Knip M. Autoimmunity and familial risk or type 1 diabetes. Curr Diab Rep 2002; 2: 347 - 353.
  • 10[4]Hamalainen AM, Ilonen J, Simell O, et al. Prevalence and fate of type 1 diabetes - associated autoantibodies in cord blood samples from newborn infants of non - diabetic mothers. Dibetes Metab Res Rev 2002;18:57-63.

共引文献41

同被引文献16

  • 1International Diabetes Federation. Diabetes Atlas. 3rd edition [ EB/OL ]. [ 2006-04-01 ]. http ://www. eatlas, idf. org/.
  • 2Ramachandran A, Mary S, Yamuna A, et al. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care, 2008,31:893-898.
  • 3Yang W, Lu J, Weng J,et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010,362:1090-1101.
  • 4Malcova H, Sumnik Z, Drevinek P, et al. Absence of breast feeding is associated with'the risk of type 1 diabetes: a casecontrol study in a population with rapidly increasing incidence. Eur J Pediatr,2006,165 : 114-119.
  • 5Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med ,2000:301-307.
  • 6Imagawa A, Hanafusa T, Uehigata Y, et al. Fulminant type 1 diabetes:a nationwide survey in Japan. Diabetes Care,2003,26 : 2345 -2352.
  • 7World Health Organization. Definition, diagnosis and classifications of diabetes mellitus and its complications. Report of a WHO consultation. Geneva: WHO, 1999.
  • 8International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care, 2009,32 : 1327-1334.
  • 9American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2010,33 ( Suppl 1 ) :S62-S69.
  • 10World Health Organization. Health experts accept use of HbAlc for diagnosing diabetes. Geneva: WHO, 2011.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部